4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-017544
Chief Legal Officer gave up 6,840 shares (to pay taxes)
- Chief Legal Officer acquired 23,812 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2021-03-01 | Option exercise | +17,175 | 143,821 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2021-03-01 | Shares withheld for taxes | −4,934 | $24.06 | $118,712 | 138,887 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-03-02 | Option exercise | +6,637 | 145,524 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2021-03-02 | Shares withheld for taxes | −1,906 | $23.25 | $44,315 | 143,618 | D |
| Derivatives | |||||||
| Ali-Jackson Kamil Chief Legal Officer | 2021-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +99,500 | 99,500 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2021-03-01 | Grant or award · Restricted stock units | +28,400 | 28,400 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2021-03-01 | Option exercise · Restricted stock units | −17,175 | 34,350 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2021-03-02 | Option exercise · Restricted stock units | −6,637 | 19,914 | D | ||
Loading xslF345X03/doc4.xml…